Metoprolol Tartrate (Immediate Release) 25 mg Tablets — Generic For Lopressor — Alembic

These highlights do not include all the information needed to use METOPROLOL TARTRATE TABLETS safely and effectively. See full prescribing information for METOPROLOL TARTRATE TABLETS.

METOPROLOL TARTRATE tablets, for oral use

Initial U.S. Approval: 1992

Indications And Usage

Metoprolol tartrate tablet is a beta-adrenergic blocker indicated for the treatment of:

Dosage And Administration

Dosage Forms And Strengths

Contraindications

Warnings And Precautions

• Abrupt cessation may exacerbate myocardial ischemia. (5.1)
• Heart Failure: Worsening cardiac failure may occur. (5.2)
• Bronchospastic Disease: Avoid beta-blockers. (5.3)
• Pheochromocytoma: Initiate therapy with an alpha blocker. (5.4)
• Major Surgery: Avoid initiation of high-dose extended-release metoprolol in patients undergoing non-cardiac surgery. Do not routinely withdraw chronic beta-blocker therapy prior to surgery. (5.5, 6.1)
• Diabetes: May mask symptoms of hypoglycemia. (5.6)
• Thyrotoxicosis: Abrupt withdrawal in patients with thyrotoxicosis might precipitate a thyroid storm. (5.7)
• Peripheral Vascular Disease: Can aggravate symptoms of arterial insufficiency. (5.9)

• Abrupt cessation may exacerbate myocardial ischemia. (5.1)
• Heart Failure: Worsening cardiac failure may occur. (5.2)
• Bronchospastic Disease: Avoid beta-blockers. (5.3)
• Pheochromocytoma: Initiate therapy with an alpha blocker. (5.4)
• Major Surgery: Avoid initiation of high-dose extended-release metoprolol in patients undergoing non-cardiac surgery. Do not routinely withdraw chronic beta-blocker therapy prior to surgery. (5.5, 6.1)
• Diabetes: May mask symptoms of hypoglycemia. (5.6)
• Thyrotoxicosis: Abrupt withdrawal in patients with thyrotoxicosis might precipitate a thyroid storm. (5.7)
• Peripheral Vascular Disease: Can aggravate symptoms of arterial insufficiency. (5.9)

Adverse Reactions

To report SUSPECTED ADVERSE REACTIONS, contact Alembic Pharmaceuticals Limited at 1-866-210-9797 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Drug Interactions

Use In Specific Populations

See 17 for PATIENT COUNSELING INFORMATION.

Revised: 8/2024